Patent applications and USPTO patent grants for Quintessence Biosciences, Inc..The latest application filed is for "non-natural ribonuclease conjugates as cytotoxic agents".
Patent | Date |
---|---|
Therapeutic ribonucleases Grant 9,579,365 - Klink , et al. February 28, 2 | 2017-02-28 |
Non-natural Ribonuclease Conjugates As Cytotoxic Agents App 20170000859 - Strong; Laura E. ;   et al. | 2017-01-05 |
Non-natural ribonuclease conjugates as cytotoxic agents Grant 9,393,319 - Strong , et al. July 19, 2 | 2016-07-19 |
Methods and compositions for the treatment of cancer Grant 9,192,656 - Kink , et al. November 24, 2 | 2015-11-24 |
Methods And Compositions For The Treatment Of Cancer App 20150238575 - Kink; John A. ;   et al. | 2015-08-27 |
Therapeutic Ribonucleases App 20150209415 - Klink; Tony ;   et al. | 2015-07-30 |
Therapeutic ribonucleases Grant 9,006,407 - Klink , et al. April 14, 2 | 2015-04-14 |
Modified ribonucleases Grant 8,840,882 - Kink , et al. September 23, 2 | 2014-09-23 |
Non-natural Ribonuclease Conjugates As Cytotoxic Agents App 20140212946 - Strong; Laura E. ;   et al. | 2014-07-31 |
Therapeutic Ribonucleases App 20140128457 - Klink; Tony ;   et al. | 2014-05-08 |
Compositions and methods for ribonuclease-based therapeutics Grant 8,697,062 - Raines , et al. April 15, 2 | 2014-04-15 |
Non-natural ribonuclease conjugates as cytotoxic agents Grant 8,697,065 - Strong , et al. April 15, 2 | 2014-04-15 |
Non-natural Ribonuclease Conjugates As Cytotoxic Agents App 20140017241 - Strong; Laura E. ;   et al. | 2014-01-16 |
Therapeutic ribonucleases Grant 8,628,768 - Klink , et al. January 14, 2 | 2014-01-14 |
Non-natural ribonuclease conjugates as cytotoxic agents Grant 8,470,315 - Strong , et al. June 25, 2 | 2013-06-25 |
Therapeutic Ribonucleases App 20120276077 - Klink; Tony ;   et al. | 2012-11-01 |
Methods and compositions for the treatment of cancer Grant 8,298,801 - Kink , et al. October 30, 2 | 2012-10-30 |
Therapeutic ribonucleases Grant 8,216,567 - Klink , et al. July 10, 2 | 2012-07-10 |
Therapeutic Ribonucleases App 20120003150 - Klink; Tony ;   et al. | 2012-01-05 |
Therapeutic ribonucleases Grant 8,029,782 - Klink , et al. October 4, 2 | 2011-10-04 |
Therapeutic Ribonucleases App 20100080789 - Klink; Tony ;   et al. | 2010-04-01 |
Compositions And Methods For Ribonuclease-based Therapeutics App 20090098101 - Raines; Ronald T. ;   et al. | 2009-04-16 |
Methods and compositions for the treatment of cancer App 20080095755 - Kink; John A. ;   et al. | 2008-04-24 |
Modified ribonucleases App 20080025964 - Kink; John A. ;   et al. | 2008-01-31 |
Methods and compositions for extracting membrane proteins App 20070026383 - Trubetskoy; Vladimir ;   et al. | 2007-02-01 |
Method for manufacturing of three dimensional composite surfaces for microarrays App 20060084159 - Trubetskoy; Vladimir | 2006-04-20 |
Non-natural ribonuclease conjugates as cytotoxic agents App 20050261232 - Strong, Laura E. ;   et al. | 2005-11-24 |
NCAGE Code | 43F94 | QUINTESSENCE BIOSCIENCES INC!DBA QBI LIFE SCIENCES |
CAGE Code | 43F94 | QUINTESSENCE BIOSCIENCES INC QBI LIFE SCIENCES |
DUNS | 003575649 | QUINTESSENCE BIOSCIENCES INC |
SEC | 0001142893 | QUINTESSENCE BIOSCIENCES INC of WISCONSIN |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.